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ABSTRACT 
 
Forces generated by body wall muscles of Caenorhabditis elegans must be 
transmitted across the worm’s thin hypodermis or “skin” to the cuticle during 
locomotion.  Fibrous organelles (FOs), structures analogous to vertebrate 
hemidesmosomes, link intermediate filaments to both the apical and basal membrane of 
the hypodermal cells and form key elements in this force transduction pathway.  Here we 
molecularly isolate the pat-12 gene and show that it encodes a component of the fibrous 
organelles. The pat-12 gene was identified through the pat-12(st430) mutation, which 
causes the embryonic body wall muscle cells to rip free from the body wall soon after 
they first begin to contract during mid-embryogenesis.  The pat-12 gene, which 
corresponds to the complex proposed gene T17H7.4, is predicted to encode 12 different 
isoforms.  The st430 mutation alters the conserved splice acceptor site of exon 12.  The 
PAT-12 protein localizes to hypodermal cells in wild-type embryos, but is absent in st430 
homozygotes.  Here, we show that two of the four isoforms that normally include exon 
12 localize to circumferential hypodermal bands characteristic of fibrous organelle 
components.  Furthermore, we propose that PAT-12 forms part of a linkage between the 
fibrous organelles and the circumferential actin bands (CFB). 
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CHAPTER 1: INTRODUCTION 
 
Hemidesmosomes and the Dermal-Epidermal Junction Zone 
To maintain tissue integrity in the presence of forces, both internally and externally 
generated, a cell employs several types of physical linkages with neighboring cells and 
the underlying lattice of the basement membrane.  These linkages, such as the vertebrate 
hemidesmosome, have been extensively characterized as to their protein components and 
interactions.  What we hope to understand is how these complexes are formed and 
correctly localized during times of transition, such as development and wound healing. 
Vertebrate hemidesmosomes (HDs) are 0.1 – 0.5 micrometer structures at the basal 
membrane of epidermal cells as well as other cells which, when examined by electron 
microscopy, appears as two electron dense regions (Borradori and Sonnenberg, 1996).  
Along with the epidermis, hemidesmosomes are found in the cornea, amnion, and parts of 
the GI and respiratory tracts.  (Borradori and Sonnenberg, 1996).  Functionally, they link 
the intermediate filaments on the intracellular side to the extracellular matrix in the 
dermal-epidermal junction zone (DEJZ) [Figure 1.1].  This region consists of the lamina 
densa (electron dense region) and lamina lucida (electron sparse region) of the basement 
membrane as well as the underlying connective tissue regions. 
To a first approximation, the connections from the epidermal cells to the dermal 
connective tissue are as follows: the intermediate filaments of the epidermal cytoskeleton 
connect to the hemidesmosome.  This in turn attaches to the anchoring filaments, which 
span the lamina lucida of the extracellular matrix.  The anchoring fibrils link to these 
filaments in the lamina densa.  The fibrils themselves extend either to anchoring plaques 
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in the connective tissue or loop back to the lamina lucida again.  Collagen fibrils can be 
caught in these fibrils loops, thus conferring even more strength to the connections 
(Bruckner-Tuderman et al. 1999). 
 
Epidermolysis Bullosa 
When these complexes are aberrant or completely missing, blistering occurs at the 
layer of the erroneous protein in response to applied stress.  This leads to a group of 
disorders collectively known as epidermolysis bullosa (EB).  First described in 1886 by 
Heinrich Koebner, EB affects approximately 1 in 50,000 individuals in the United States 
(Fine et al, 2008, Prockop and Malwina, 2008).   Molecularly, EB is due to mutations in 
at least 10 proteins, which are members of the hemidesmosomes or their attachments 
within the basal lamina (Sawamura at al. 2010, Nagy and McGrath 2010, Fine et al. 
2008).  The prevalence of blisters and their localization varies highly depending on both 
the aberrant protein and the causal mutation.  Phenotypic variation occurs even 
individuals with similar mutations leading to the thought that the ultimate disease state 
can be affected through modification by other related proteins. 
In addition to epidermal blistering, patients with EB develop extra-dermal 
manifestations of the disease as well.  Most striking among these is “mitten deformities,” 
which refer to progressive webbing of the fingers (pseudosyndacytly) (Fine and Mellerio 
2009).  Surgical correction of these hand deformities through de-gloving procedures is 
possible and has good results, but must be repeated every 2 years, on average (Fine and 
Mellerio 2009).  Muscular dystrophies, osteoporosis, dilated cardiomyopathy, enamel 
hypoplasia, delayed puberty, anemia, frequent infections, and squamous cell carcinoma 
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are other possible systemic manifestations in these patients (Fine and Melleria 2009).  
Activities of daily living can be limited due to pain in showering, dressing, etc. 
EB was classified into major types based on the blistering pattern and the aberrant 
protein at the Third International Consensus Meeting on Diagnosis and Classification of 
EB.  These four classifications are epidermolysis bullosa simplex (EBS), junctional 
epidermolysis bullosa (JEB), dystrophic epidermolysis bullosa (DEB), and Kindler 
Syndrome (mixed epidermolysis bullosa) (Fine et al. 2008).  Additionally, an 
autoimmune blistering disorder termed epidermolysis bullosa acquisita (EBA) has been 
described (Lehman et al. 2009). 
 
Basal Epidermal Layer 
The basal epidermal layer is the site of the stem cells that give rise to the overlying 
layers of stratified epithelium.  It provided a barrier to the free movement of molecules 
and cells as well as minimizing water loss from the underlying tissues.  By excreting 
fibrous molecules, it also plays a role in the formation of the basement membrane 
(Burgeson and Christiano, 1997). 
The hemidesmosome is positioned at the basal membrane of these keratinocytes.  The 
foundation of the hemidesmosome is the transmembrane α6β4 integrin, which have been 
reported to be necessary for HD formation as HDs are absent in animals null for either 
subunit (Koster et al, 2003).  This particular combination of integrin subunits is specific 
to mature epithelium (Burgeson and Christiano, 1997).  The β4 cytoplasmic domain 
appears to play the major role in protein recruitment to the HD via the four pairs of 
fibronectin type III (FNIII) domains and the intervening connecting sequence (CS) in its 
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cytoplasmic domain.  The second FNIII domain is key in the binding to plectin, the third 
in the interaction with BP180.  An additional domain appears to mediate interactions with 
BP230 (Koster et al, 2003). 
Plectin and BP230 are both members of the plectin protein family.  Both serve as 
adapters between the α6β4 integrin and the intermediate filaments.  BP230 requires both 
plectin and BP180 for correct localization (Koster et al, 2003).  
BP180 is an additional transmembrane protein that appears to help stabilize the HD 
that has been seeded with the α6β4 integrin.  It may also be able to bind laminin 5 like 
α6β4 integrin.  The current model is an initial interaction between α6β4 integrin and 
plectin is further organized by the binding of BP180.  BP230 is then recruited thereby 
increasing possible interactions with intermediate filaments in the cytoskeleton.  While 
this model appears to hold true in vitro, the situation in vivo may be a bit more complex 
as HDs can still form in a plectin-deficient model (Koster et al, 2003). 
 
Epidermolysis Bullosa Simplex (EBS) 
Abnormal or absent connections within the epidermis between the keratin 
intermediate filament (IF) network and hemidesmosomes results in EBS and affects 
about 1 in 25,000 live births worldwide (Coulombe et al. 2009).  The characteristic 
blistering pattern seen in these patients occurs within the layer of the basal keratinocytes 
of the epidermis and does not lead to disruption of the basement membrane.  In contrast 
to the other EB major subtypes, blisters in EBS hear with no scar due to the favorable 
plane of separation (Coulombe et al. 2009).   
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The vast majority of these cases result from mutations in either keratin 5 or 14, a 
Type I / Type II pair of IFs within the hypodermis (Coulombe et al. 2009).  Since these 
keratins form heterodimers of Type I and Type II keratins, mutations in one can lead to 
loss-of-function (in the case of null mutants) or dominant negativity (Coulombe et al. 
2009), with the phenotype from dominant negative mutations being more severe than the 
null.  The phenotype from these mutations can be modulated by other keratins (such as 
K15), which can at least partially rescue the effects of such a mutation by replacing the 
aberrant protein within the heterodimer.  Molecularly, the erroneous IF fibers are more 
fragile than their wild type counterparts and, therefore, fail in response to applied stress. 
Mutations in the more severe EBS patients, such as the generalized subtype, have 
been localized to regions of the gene encoding the helix initiation and termination motifs.  
Mutations in other areas of the gene, such as that that encodes the linker region, correlate 
with less severe pathologies.  The most severe of these subtypes is EBS with muscular 
dystrophy (or EBS-MD).  Blistering in these individuals was noted by electron 
microscopic examination to be just within the plasma membrane of the basal 
keratinocytes.  Additionally, muscle cells in these individuals were noted to be 
disorganized with varying muscle fiber lengths and areas of atrophy and regeneration.  
This condition, unlike those previously described, is due to mutations in the plectin gene.  
Plectin (or HD1) is located in the cytosolic (or inner) electron dense region of the 
hemidesmosome and loss of this protein results in disruption of keratin attachment to the 
hemidesmosome.  Transmission of this condition is autosomal recessive and the blisters  
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appear in a generalized pattern.  Blisters can be present from birth in these patients, but 
the onset of the muscular dystrophy is often not until infancy or adulthood (Smith et al. 
1996). 
 
Kindler Syndrome 
First described in 1954 by Theresa Kindler in a 14 year-old patient with congenital 
blistering on her hands and feet, Kindler Syndrome also results from epidermal layer 
blistering and is caused by mutations in the KIND1 gene, which encodes the kindling-1 
protein.  This protein shares homology with the C. elegans protein UNC-112, which has 
been shown to function in the attachment of actin to the extracellular matrix.  Therefore, 
it has been hypothesized that kindling-1, which has a talin-like domain that could attach 
to actin and a pleckstrin homology (PH) domain that could bind to phosphatidylinositol 
phospholipids in the cell membrane, could serve as an actin-membrane link (Seigel et al, 
2003).   
Kindler Syndrome is very rare, with less than 100 cases in the medical literature, but 
does have a cluster of patients in a group of Native Americans in Panama.  Patients 
displaying this disease have blistering of the skin from birth to adolescence as well as 
skin fragility in sun exposed areas and changes in pigmentation (hyper- and 
hypopigmentation are seen).  As adults, the blistering lessens, which has been postulated 
to indicate that this connection is relied upon more readily by children and that the 
hemidesmosome-mediated linkage is more robust and able to compensate in adults 
(Seigel et al, 2003).   
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Basement Membrane Layer 
The basement membrane is a fibrous layer which supports the epidermis, is a scaffold 
for migrating cells, and controls the passage of molecules and cells to and from the 
epidermal layer (Burgeson and Christiano, 1997).  Laminin 5 (Laminin 332) is the major 
component of the adhesion complex through the basement membrane.  A heterotrimer 
made up of an α3, a β3, and a γ2 subunit (hence the 332 designation), it is encoded by 
three subunits, the LAMA3, LAMB3, and LAMC2 genes respectively and are assembled 
intracellularly prior to secretion (Aumailley and Rousselle, 1999, Jonkman, 1999).  Each 
subunit contains a highly conserved region at the carboxy terminus made of heptad 
repeats, which in the final molecule combine to form a coiled coil motif.  Extending 
beyond this on the α3 subunit is an additional globular domain termed the LG domain.  
Together the three subunits form a cruciform shape with the amino termini variable 
region of each subunit hanging free (Aumailley and Rousselle, 1999).   
Laminin 5 localizes to the lamina lucida of the extracellular matrix underlying the 
epithelia.  It serves as a linkage between the α6β4 integrin on the epidermal basal cell 
membrane and the collagen VII anchored into the lamina densa (Aumailley and 
Rousselle, 1999).  Additionally, laminin 5 associates within the ECM with laminins 6 and 
7, which allows it to link into the meshwork ECM network of perlecan and Type IV 
collagen via nidogen (Jonkman, 1999). 
 
Junctional Epidermolysis Bullosa (JEB) 
JEB results from a loss or alteration in the laminin 5 protein within the extracellular 
matrix (Aumailley and Rousselle, 1999).  There are two major types of JEB based on 
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severity of phenotype and type of mutation seen in the three genes encoding laminin 5, 
LAMA3, LAMB3, and LAMC2.  Both types show autosomal recessive transmission.  
The more severe type, Herlitz-JEB, is due to a premature stop codon within these genes 
(Aumailley and Rousselle, 1999).  Patients showing this disorder have an abundance of 
blistering early in infancy and often die secondary to related infections (Fine et al. 2008).  
Patients with the non-Herlitz, generalized type of JEB, which is due to missense 
mutations in the laminin 5 genes, are much less likely to die from associated infections 
before adulthood (Aumailley and Rousselle, 1999, Fine et al. 2008).  Therefore, in these 
cases null mutation is more severe than dominant negative. 
There are several minor types of JEB, which are due to mutations in α6β4 integrin 
and collagen XVII.  Mutations in α6β4 integrin lead to JEB with pyloric atresia (JEB-
PA).  Blisters in JEB-PA also show a generalized distribution, display pyloric atresia, and 
have multiple other malformations within the GI tract.  Death due to EB complications in 
JEB-PA is equivalent to patients with the Herlitz type of JEB.  Associated with mutations 
in the gene encoding collagen XVII, JEB, non-Herlitz type, localized is the mildest form 
of JEB described thus far.  Blistering is localized to discreet regions in the skin and oral 
mucosa only, with no other systemic manifestations.  Death from localized JEB is rare 
(Fine et al. 2008). 
 
Dermal Connective Tissue Layer 
Underlying the basement membrane, the dermal layer provides additional structural 
support for the epidermis as well as housing blood vessels and immune cells that further 
maintain the overlying cells (Goldman and Ausiello, 2008).  This are the site of the 
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anchoring fibrils that complete the anchoring constructs.  The major component of these 
anchoring fibrils, collagen VII, is encoded by the COL4A1 gene.  This is an enormous 
gene spanning 32 kb and containing 118 exons.  Each final collagen VII is composed of 
three α1 subunits, which each contain a central triple helix collagenous domain and two 
non-collagenous domains, NC1 and NC2, at the amino and carboxy terminus 
respectively.  The triple helix domain contains repeating runs of –Gly-X-Y- with periodic 
non-collagenous segments interspersed, which are thought to confer a certain amount of 
flexibility to the molecule.  The largest of these segments is a 39 amino acid stretch near 
the center of the triple helix termed the “hinge region.”  Collagen VII is translated as pro-
collagen VII and is post-translationally modified with the cleavage of the NC-2 domain 
(Bruckner-Tuderman et al. 1999).   
The final molecules arrange themselves into fibrils in a tail-to-tail fashion, with the 
NC-1 domains pointing outwards.  With the NC-1 domain, the fibrils attach into either 
the lamina densa, interacting directly with β3 or γ2 domain of laminin 5, or anchoring 
plaques in the dermis.  As these fibrils hook back to the basement membrane, they trap 
dermal collagen within these loops, thus providing additional strength to the connections 
(Bruckner-Tuderman et al. 1999). 
 
Dystrophic Epidermolysis Bullosa (DEB) 
Dystrophic EB (DEB) is characterized by separation within the dermal connective 
tissue layer of the skin, below the lamina densa.  Most cases of this are due to mutations 
in the collagen VII encoding gene, COL7A1 (Bruckner-Tuderman et al. 1999).  
Mutations in COL4A1 can lead to a range of phenotypes from a complete loss of fibrils, 
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in DEB mutilans, to a relatively simple disordering of the fibrils.  Interestingly, a loss of 
50% of these fibrils is not sufficient to cause a mutant phenotype.  Given that the 
collagen VII protein is composed of an alpha helical core, one would think that point 
mutations leading to the replacement of glycine residues with amino acids with larger 
side groups would have a profound effect on function.  Surprisingly, though these would 
be assumed to disrupt the alpha helices, mild or no mutant phenotype is noted.  
Heterozygocity for several COL7A1 mutations is often necessary for displaying the most 
severe phenotypes (Bruckner-Tuderman et al. 1999).   
A related disorder to DEB is epidermolysis bullosa acquisita (EBA), which results 
from an autoimmune reaction with collagen VII.  Most of these antibodies are found to 
react with the NC-1 domain and thus disrupt fibril binding within the lamina densa.  
Blistering in these patients also results from separation below the level of the lamina 
densa (Bruckner-Tuderman et al. 1999). 
 
Studying Adhesion Complexes in C. elegans 
While many of the vertebrate protein10s and their interactions have been identified, 
how these connections assemble and correctly localize during development has not been 
extensively characterized.  In order to achieve this, we suggest examining a similar 
system in the simpler nematode, Caenorhabditis elegans.  Due to their small size, short 
generation time, well-characterized development, ease of transgenic animal generation 
and transparency, C. elegans represents a convenient system for studying cell-matrix 
connections in vivo.  Additionally, an extensive amount of genetic information has been 
gathered on the worm and is available on-line through wormbase.org.   
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Caenorhabditis elegans hypodermal cells contain attachment structures that are 
functionally analogous to the vertebrate Type I hemidesmosome and are termed fibrous 
organelles (FOs)  (Andrä et al, 1997).  Like hemidesmosomes, fibrous organelles are 
composed of two electron dense regions, approximately 200 nm in diameter, one on the 
apical side of the hypodermal cell and one on the basal, that are connected by 
intermediate filaments (Nievers et al, 1999) [Figure 1.2].  The apical-basal distance 
between these plaques is about 200 nm
 
(Nievers et al, 1999).  FOs are positioned within 
the hypodermis specifically where it overlies the body wall muscles (Hahn and 
Labouesse, 2001).  The role of these FOs is to transmit force generated by body wall 
muscles across the hypodermis to the overlying cuticle, which serves as the worm's 
exoskeleton.   
Many of the protein components of the FO have been previously identified.  These 
include transmembrane proteins at the basal (LET-805 / myotactin) and apical (MUA-3, 
MUP-4) hypodermal cell membranes.  Myotactin is thought to interact with the ECM via 
its fibronectin type III repeats, maintaining the link between the hypodermis and the 
muscle (Hresko et al., 1999).  MUA-3 and MUP-4 are thought to provide connections to 
the cuticle and may be able to interact directly with IFs via their filliggrin-like repeats 
(Bercher et al., 2001; Hong et al., 2001).  The identified adapter protein VAB-10A may 
serve as a link from the transmembrane proteins to the IFs at both the apical and basal 
sides of the hypodermis (Michaux et al., 2001).  Another protein, VAB-19, has been 
described as an FO component and though its function has yet to be fully determined, it 
has been proposed to play a role in actin cytoskeletal organization (Ding et al., 2003).  
Mutants of myotactin, vab-19, and vab-10a as well as the intermediate filaments genes 
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ifb-2 and ifa-3 arrest at the two-fold stage of development and are paralyzed (Ding et al., 
2003; Hresko et al., 1999; Woo et al., 2004; Ding et al., 2004), likely due to failure of the 
mechanical linkage between the body-wall muscles and the cuticle.  Mutants in mua-3, 
mup-4, and mua-6 show muscle separation defects in the larval stages of development. 
 
The Pat Phenotype and Muscles 
The search for additional members of the FO developed through a screen for proteins 
involved in c. elegans body wall muscle attachment.  The contractile apparatus of C. 
elegans body wall muscle is attached to the extracellular matrix through a focal adhesion 
complex, which is similar to dense bodies and M-lines in vertebrate muscles.  Williams 
and Waterston sought to determine additional members of this complex after screens for 
mutations in genes causing abnormal movement and obvious muscle disorganization had 
reached a point of saturation.  In order to identify these extra muscle component proteins, 
they took advantage of a mutant phenotype noted for muscle-related genes myo-3, deb-1, 
and unc-45 (Williams and Waterston, 1994).   
In each of these mutants, worms developed normally until the one-and-a-half-fold 
stage of development (~400 minutes post-fertilization).  In wild-type animals, embryos at 
this stage begin to twitch and then roll vigorously within the egg as the body-wall 
muscles begin to contract.  In the mutants described above, the embryos mildly twitched, 
failed to roll, and their development was halted at the two-fold stage (~450 minutes post-
fertilization) [Figure 1.3].  They termed this the Pat phenotype (Paralyzed and Arrested at 
Two-fold) (Williams and Waterston, 1994). 
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Using this phenotype as the target in a screen, Williams and Waterston identified 16 
genes, including ten novel genes, named pat-2 through pat-6 and pat-8 through pat-12.  
Based on the organization of the myosin heavy chain A in their mutants, these genes were 
classified into four classes, ranging from complete MhcA disorganization in class I to 
partial organization in class IV (Williams and Waterston, 1994). 
Since their original screen, many of the pat genes have been characterized and noted 
to be involved in muscle attachment.  pat-2 was shown to encode a homolog of α-
integrin, with pat-3 encoding a corresponding β-integrin.  These serve as the 
transmembrane link from the muscle contractile apparatus to the overlying extracellular 
matrix (Williams and Waterston, 1994).  pat-4 was shown by MacKinnon et al to 
correspond to the vertebrate Intergrin-Linked Kinase (ILK).  MacKinnon et al also 
produced a kinase-dead pat-4 mutant, which had no abnormal phenotype suggesting that 
the kinase domain does not play a major role in C. elegans muscle activity or 
development (MacKinnon et al, 2002).  pat-6 was determined to be a homolog of 
vertebrate actopaxin, a known focal adhesion protein (Lin et al. 2003). 
Mild Pat mutants, such as the pat-12 mutant, were noted to have muscle contractile 
elements that developed better than in severe Pat mutants, but degenerated secondarily to 
cell rupture.  Also, these animals rolled in their egg prior to their arrest at the two-fold 
stage.  Williams and Waterston noted that both the myosin based A band and actin based 
I band became partially organized in the pat-12 mutants.  In fact, they hypothesized that, 
since they were unable to definitively determine the age of the arrested mutants, it is 
possible that those examined represented animals that had were much older that the ~400 
minute post-fertilization that a normal Pat would arrest at and that the disorganization of 
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the muscle contractile elements seen could have been a secondary deterioration.  The pat-
12 mutants did bear a striking resemblance to mutants in the emb-9 gene, which encodes 
type IV collagen, a basement membrane component.  They stated that this would be 
consistent with PAT-12 localizing outside of the body wall muscle cell (Williams and 
Waterston, 1994). 
Because of the subtle differences in its mutant phenotype, we believe that PAT-12 is 
not a component of the muscle contractile apparatus like the severe Pats.  We hypothesize 
that it is a member of the C. elegans fibrous organelle and plays an important role in 
maintaining connections between the hypodermis and muscles at the time when muscles 
begin contraction.  In this way, PAT-12 resembles various hemidesmosomal proteins in 
its function.  By studying PAT-12 and its role in forming and maintaining the FO, we 
hope to learn how a FO organizes and localizes.  We hope, then, to apply the lessons 
learned from this back to the vertebrate model and see what correlations that can be 
drawn to hemidesmosomes. 
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Figures 
  
Figure 1.1:  Diagram of Vertebrate Hemidesmosomes and the Dermal-Epidermal 
Junction Zone (DEJZ). - The hemidesmosome links epidermal keratins (5 and 14) to 
laminin 5 in lamina densa.  Laminin 5 also links to type IV collagen in lamina densa via 
laminin 6 and nidogen (not shown).  Laminin 5 then binds to anchoring fibrils composed 
of type VII collagen, which then trap interstital collagen located in the dermis in their 
fibers 
.
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Figure 1.2:  Diagram of Known Fibrous Organelle Proteins. - MUP-4 and MUA-3 act as 
transmembrane connectors into the overlying cuticle.  Myotactin interacts at basal 
membrane with fibronectin in basement membrane. 
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Figure 1.3:  Comparison of Wild Type Embryonic Development with Pat Development. - 
Development progresses in an identical manner until the two-fold stage of development 
when the Pat embryos fail to continue elongation and arrest with paralysis.  From 
Williams and Waterston, 1994. 
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CHAPTER 2: IDENTIFICATION OF T17h7.4 AS pat-12 
 
Introduction and Rationale 
In order to determine the sequence of events that result in the formation of the fibrous 
organelle, we must first know the members of the complex.  In order to know 
characteristics of the member proteins, it is helpful to identify the genes that encode 
them.  We chose to first establish the identity of the gene encoding the PAT-12 protein 
because of the clear mutant strain available (st430) and its mild Pat phenotype that was 
different than Pats that are known to be involved in muscle attachment. 
Since Williams and Waterston had mapped pat-12 to chromosome III between unc-45 
and daf-7 (Williams and Waterston, 1994) [Figure 2.1], we limited our search of 
candidate genes for pat-12 to this area.  Because RNAi experiments are both so easy to 
perform and since significant amounts of data from high through-put RNAi screens have 
been widely published, we used this method as a first step of identifying possible pat-12 
genes.  We took a two-step approach, which took advantage of both of these facts.  By 
first searching available large scale RNAi screens for genes in this region with reported 
lethal phenotypes for wormbase.org, we could identify potential pat-12 gene candidates.  
We then could perform our own RNAi experiments on these genes to determine if any of 
the lethal phenotypes were specifically Pat phenotypes. 
After this study, we would expect to have one or more genes that displayed both a 
reported embryonic lethal phenotype and a Pat phenotype in a significant proportion of 
the offspring of injected adults in our studies.  To prove which of these candidate genes 
actually corresponds to pat-12, we would then undertake to inject full gene sequences, in 
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the form of cosmids containing the gene, into pat-12(st430) heterozygous adults to check 
for rescue in their progeny.  Although this is a time-consuming process, it would provide 
definitive results and would be possible if done on only a few candidate genes.  
Successful rescue by any of these cosmid injections would indicate that the gene 
contained on that cosmid is pat-12.   
Once we have the gene identified, we could then seek the mutant that causes the Pat 
phenotype by full gene sequencing in a pat-12(st430) homozygous mutant animal.  This 
would not only confirm our previous results, but might give some indications of a critical 
region of the gene, as noted with some of the genes noted above, such as the gene 
encoding keratin 5 and 14.  Additionally, we can examine the gene sequence for any 
clues as to the function of PAT-12 in the form of conserved protein sequences or 
homologies.  In this way, we would form the foundation on which further experiments on 
the PAT-12 protein could be based. 
 
Materials and Methods 
 
Strains Used 
The following C. elegans strains were used for the experiments in this chapter: N2 
(which is assumed to be wildtype in all experiments), RW1389 [pat-12(st430)/unc-
45(e286)daf-7(e1372)], WB297 [pat-12(st430); zpEx311], and OT170 [mua-6(nc16); 
erIs1].  All C. elegans strains were grown on NGM plates seeded with the Escherichia 
coli strain OP50 (Brenner 1974). 
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Construction of Transgenic Lines 
We generated all transgenic lines through microinjection as described by Mello and 
Fire (Mello and Fire, 1995).  In each injection, the plasmid pRF4 [rol-6 (su1006dm)] was 
used (at approximately 150 ng µl
-1
) as a marker due to the stereotypic phenotype of a 
rolling locomotion seen in expressing animals.  F1 worms displaying the Rol phenotype 
were cloned, allowed to self-cross, and the F2 were examined for rolling progeny.  All 
injected lines were considered stable when the balancer phenotype was lost and the roller 
phenotype was observed in the 2nd generation progeny of injected worms.  The 
extrachromosomal array zpEx311 in the strain WB297 was generated by injection of a 
solution containing the cosmids F20B8, C24A1, and F42G9 each at concentrations of 
approximately 10.5 ng µl
-1
.   
 
RNAi 
RNA interference was performed as described by Fire et al (Fire et al., 1998).  The 
cDNA clones yk287e3 and yk15d2, both corresponding to the gene T17H7.4, were 
amplified independently by PCR using the T7 and T3 primers.  Sense and antisense 
strands of RNA were generated from these PCR products using the MEGAscript T3 and 
T7 High Yield Transcription Kit (Ambion).  The sense and antisense strands 
corresponding to each cDNA clone were combined, and purified as described by 
Sambrook and Russell (Sambrook and Russell, 2001), and resuspended in TE pH 8.0.  
The RNAs corresponding to these two cDNA clones were the combined and injected into 
N2 (wildtype) hermaphrodites.  Only eggs that were laid between 12 and 48 hours after 
injection were scored for the Pat phenotype.  
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Sequence Analysis 
To determine the genetic lesion in pat-12 allele st430, the following primers, which 
span the length of the predicted gene T17H7.4, were used: BW-241, BW-242, BW-245, 
BW-246, BW-249, BW-250, BW-253, BW-254, BW-257, and BW258.  Whole N2 
(wildtype) worms and 6-8 arrested pat-12 homozygous embryos were incubated in 5 µl 
of lysis buffer (50 mM KCl, 10 mM Tris (pH 8.3), 2.5 mM MgCl2, 0.45% Nonidet P-40, 
0.45% Tween-20, and 0.01% (w/v) gelatin) with proteinase K (60 µg/ml) at –80˚C for 10 
minutes, 65˚C for 60 minutes, and 95˚C for 15 minutes (Williams 1995).  PCR fragments 
were generated using these genomic DNAs by the following protocol: 94˚C for 30 
seconds, 55˚C for 30 seconds, 68˚C for 2 minutes 30 seconds, repeated 29 times and held 
at 4˚C.  Fragments were prepared for sequencing using the BigDye Terminator Cycle 
Sequencing Kit (ABI, PE Corporation).  Samples were sequenced at the University of 
Illinois Biotechnology Center.  Sequences from Pat embryos were then compared to 
those of wild-type worms to determine base pair differences. 
 
Results 
 
Molecular Identity of pat-12 
We sought to determine the molecular identity of pat-12 through positional cloning in 
combination with RNA interference (RNAi), transgenic phenotypic rescue, and sequence 
analysis.  Williams and Waterston mapped pat-12 to linkage group III between unc-45 
and daf-7 (Williams and Waterston, 1994) [Fig. 2.2A].  This interval contains 52 
predicted genes, 7 of which are reported in large-scale screens to display an embryonic 
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lethal RNAi phenotype.   This phenotype was reported most frequently for one predicted 
gene in this interval, T17H7.4 (Rual et al., 2004; Simmer et al., 2003; Sönnichsen et al., 
2005; Tsuboi et al., 2002; Green et al., 2004; Gonczy et al., 2000; Kamath et al., 2003).  
Therefore, we repeated the RNAi experiment focusing on this predicted gene as the most 
likely candidate.  Our RNAi experiments resulted in a 97.8% Pat F1 progeny rate 
(n=338), confirming that this embryonic lethal phenotype was a Pat  phenotype.  This 
result established T17H7.4 as a promising pat-12 candidate.  Because this result was so 
positive, we decided to move forward looking only at this gene rather than trying to 
identify other possible candidate genes. 
To determine directly whether T17H7.4 is pat-12, we attempted to rescue the st430 
mutant phenotype with the corresponding cosmids.  Initially, we focused on three 
overlapping cosmids, C24A1, T17H7, and F42G9 (provided by Dr. Alan Coulson).  After 
we were unable to rescue using these cosmids, we performed restriction enzyme 
digestions to determine if they were completely intact.  In all of these trials, T17H7 
showed a large deletion (data not shown).  To overcome this, we used a non-canonical 
cosmid, F20B8, which corresponds to T17H7 (also provided by Dr. Alan Coulson).  
Digestions of this cosmid showed it to be intact (data not shown). 
All three cosmids, C24A1, F20B8, and F42G9 [Figure 2.1 and 2.2B], are required 
together because the entire promoter and coding region of T17H7.4 is approximately 24.7 
kb [Fig. 2.2B].   Individually, none of these three cosmids include the entire predicted 
T17H7.4 coding region.  We were able to establish a viable transgenic line using an 
extrachromosomal array made by co-injecting all three cosmids that rescued the two-fold 
arrest of pat-12(st430) homozygotes.  The individual injection of any one of these 
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cosmids was insufficient to rescue the st430 mutation.  We were only able to generate 
one transgenic line from this experiment, likely due to the rarity of in vivo crossover 
events occurring to generate a full length pat-12 gene with flanking promoter and 3’ 
untranslated regions.  These results are consistent with the identification of T17H7.4 as 
pat-12. 
To further confirm this identification and to attempt to obtain additional information 
concerning the pat-12 gene, we looked for the pat-12(st430) genetic lesion in T17H7.4 by 
DNA sequence analysis.  Initially, we used a predicted gene map that included only 3 
splice isoforms and lacked the first four exons of isoform K.  We isolated the entire 
predicted coding region of T17H7.4 at that time by PCR from both wild-type adults and 
arrested pat-12 homozygous embryos and compared the DNA sequences.  Fortuitously, 
we found only one change that happened to be in this region, a single guanine to adenine 
transition in the splice acceptor site of the 12
th
 exon in the st430 embryos compared to the 
wild-type [Fig. 2.2C].  This mutation alters the highly conserved AG splice acceptor 
sequence (Ding et al., 2003; Blumenthal and Steward, 1997) [Fig. 2.3] and most likely 
would result in the loss of exon 12.  Of the 12 current predicted isoforms of T17H7.4 
from wormbase.org, exon 12 is included in only four: isoforms A, C, J and K [Fig. 2.1C].  
Our results, therefore, confirm that T17H7.4 is pat-12, and further suggest that a 
deficiency in one or more of these four PAT-12 proteins is responsible for the muscle 
detachment and subsequent developmental arrest in pat-12(st430) mutants.  They also 
suggested exon 12 as a possible critical region to further investigate by examining 
sequence homologies with vertebrate genes. 
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Discussion 
The original description of the pat-12 “mild” Pat phenotype suggests that this gene is 
required at some level for the stable attachment of body wall muscle cells to the 
hypodermis during embryogenesis.  Because its mutant phenotype is so different than 
that of previously identified Pat genes that are known to encode muscle attachment 
proteins, we suspected that PAT-12 did not localize to the focal adhesion complexes.  
Additionally, Williams and Waterston hypothesized that since a severe disruption of the 
muscle contractile apparatus was not seen until after the stage of arrest, it was probably 
not an intricate part of the muscle assembly, and may be acting in the hypodermis 
(Williams and Waterston, 1994).  We have shown here that the genetically defined pat-12 
locus corresponds to the proposed gene T17H7.4 by RNAi, genetic rescue, and mutation 
identification. 
The proposed gene T17H7.4 encodes 12 predicted isoforms and extends over about 
25 kb of chromosome III [Fig. 2.2C].  Examination of the sequences of all 12 predicted 
isoforms of T17H7.4 and their protein products revealed no conserved domains, NLS, 
NES, or transmembrane sequences, suggesting that all are cytosolic proteins.  No areas of 
conserved domains were noted in the exon (exon 12), which we predict would be lost in 
the pat-12(st430) homozygous mutant.  The four predicted isoforms, A, C, J, and K, 
likely affected by the st430 mutation encode proteins of 663, 706, 716, and 657 amino 
acids respectively. 
BLAST searches of these protein sequences identified only three closely related 
proteins, OvB20 in Onchocerca volvulus and B20-1 and B20-2 in Brugia malayi, but no 
clear vertebrate homologs. OvB20 is a protein characterized in larva of Onchocerca 
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volvulus, a cause of onchocerciasis in cattle and has been studied as a possible target for 
immunization.  It was shown to localize to discrete area in the hypodermis and cuticle of 
larvae.   Vaccination against this protein offered protection from onchocerciasis in 
rodents (Taylor et al., 1995). 
The specific mutation in the st430 mutant, the G to A mutation, is at a highly 
conserved splice acceptor site of exon 12.  Blumenthal and Steward note that this site is a 
CAG in 85% of introns that were examined in C. elegans (Blumenthal and Steward, 
1997).  Aroian et al., however, describe mutations in three genes, let-23, dpy-10, and let-
23, in which a similar G to A mutation at the splice acceptor site did yield some correctly 
spliced RNA copies.  Each of these introns was small [53, 48, and 316 nt respectively], 
whereas the intron proceeding exon 12 is about 800 nt in length.  The authors here 
suggest that larger introns could be spliced to a mutant AA sequence or a nearby AG, but 
it is clear from their data that other transcripts will be present in significant quantities 
(Aroian et al, 1993). 
If some of the original transcript can be made and spliced like the wild type, the 
question becomes: why does this not rescue the mutant phenotype.  The first possibility 
could be a dosing issue.  Aroian et al. stated that in the case of the genes they examined, 
only about 52% of the transcripts were approximately the same length as the wild type.  
This allowed for the use of aberrant splice site near the proper site (Aroian et al, 1993).  If 
there is a certain threshold amount of PAT-12 necessary for muscle attachment at the 
two-fold stage, this lower amount may not be enough to function. 
Secondly, the improperly spliced transcripts may be exerting a dominant negative 
effect on the wild type copies.  This would be more likely the case if it appeared the 
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PAT-12 was playing a signaling role and not a structural role as we propose.  If this were, 
in fact, the case, rescuing the mutants with any construct that is not a major over 
expression of pat-12 would be very difficult or impossible.  Further studies localizing 
PAT-12 in wildtype and mutant animals are needed to differentiate these.  We will 
describe these experiments in the next chapter. 
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Figures 
 
Figure 2.1:  Physical Map of Area Between unc-45 and daf-7 from Chromosome III with 
Cosmids Contained Therein. - Cosmids containing unc-45 and daf-7 are in red.  Cosmids 
injected for rescue of the pat-12(st430) mutation or the canonical cosmids representing 
them [T17H7 is the canonical cosmid for F20B8] are shown in yellow. 
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Figure 2.2:  Gene Map of pat-12 from Chromosome III. - (A) pat-12 is located in a 300 
kb region between unc-45 and daf-7.  (B) Three overlapping cosmids together contain the 
coding region and 5’ UTR of pat-12, F42G9, F20B8, and C24A1.  (C) 12 potential 
isoforms of pat-12 have been predicted.  The area of the G to A mutation in the st430 
mutants is highlighted.  Isoforms predicted to be affected by the st430 mutation (J, A, C, 
and K) are marked in blue.  The star indicates the region of pat-12 that is targeted by the 
anti-pat-12 antibody 
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Figure 2.3: C. elegans Consensus Sequence of Splice Donor and Splice Acceptor Site for 
Cis-splicing - Both 5’ and 3’ site are with respect to intron [5’ is splice donator, 3’ is 
splice acceptor].  Consensus sequence of CAG is present at splice acceptor site in 85% of 
introns examined.  The pat-12(st430) mutation is a G to A mutation in the –1 position of 
the 3’ splice site.  Adapted from Blumenthal and Steward,1997. 
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 CHAPTER 3: PAT-12 PROTEIN 
 
Introduction and Rationale 
With the identity of pat-12 now known as T17H7.4, we turned our attention to the 
attributes of the PAT-12 protein.  The only additional information that we gained from 
examination of the sequence of PAT-12 was that it is a cytosolic protein since it lacked a 
transmembrane domain.  With no further clues to its function, we now worked to 
elucidate this by examining its expression and specific sub-cellular localization.   
The first question that needed to be addressed was which isoform or isoforms, if any, 
are present in the hypodermal cells and thus likely involved in the fibrous organelle.  We 
chose to approach this by a two-fold method of generating an anti-PAT-12 antibody and 
transcriptional fusion products corresponding to various isoforms.  The first of these 
methods offers a reagent that will be invaluable for future experiments and can also be 
used to determine sub-cellular localization, but does not differentiate between isoforms 
that contain the sequence used as an antigen.  While the second gives information on 
which isoforms are expressed by the hypodermal cell, provided they use different 
promoter regions, it does not allow for the precise protein localization.  Therefore, we 
needed the two in conjunction to delineate which isoforms on which to focus future 
experiments.  Additionally, we chose these two specific methods to determine this 
because of their success in experiments on previous Pat proteins (PAT-4, PAT6) 
(MacKinnon et al, 2002, Lin et al, 2003). 
To determine the specific sub-cellular localization of PAT-12 we have elected to once 
again use our new anti-PAT-12 antibody, supplementing it with translational fusion 
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products (containing gfp in frame) corresponding to the hypodermally expressed isoforms 
previously noted.  Once again, these two lines of experimentation compliment each other.  
By staining animals with our antibody and those directed at previously identified fibrous 
organelle proteins, we can determine if PAT-12 localizes with this structure.  Also, the 
reagent affords us the opportunity to stain pat-12(st430) homozygous mutant animals to 
elucidate whether any PAT-12 protein is present in these animals.  The translational 
fusion constructs will allow us to confirm antibody data and also view PAT-12 
localization in a live animal.   
Furthermore, we could look at PAT-12::GFP expressing animals over the course of 
their development to see if expression of different isoforms changes.  As noted in chapter 
one, members of hemidesmosome related adhesion complexes, such as keratins, are 
replaced by other similar proteins during development.  In this way PAT-12 could be 
lending some flexibility to the fibrous organelle in response to environmental alterations.  
Ultimately, we desire to place PAT-12 within the fibrous organelle and, building on 
previous work of other member protein, create a foundation on which experiments to 
determine the sequence of events that mark the FO formation. 
 
Materials and Methods 
 
Strains Used 
The following C. elegans strains were used for the experiments in this chapter: N2 
(which is assumed to be wildtype in all experiments), RW1389 [pat-12(st430)/unc- 
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45(e286)daf-7(e1372)], WB297 [pat-12(st430); zpEx311], and OT170 [mua-6(nc16); 
erIs1].  All C. elegans strains were grown on NGM plates seeded with the Escherichia 
coli strain OP50 (Brenner 1974). 
 
Construction of Transgenic Lines 
 
We generated all transgenic lines through microinjection as described by Mello and 
Fire (Mello and Fire, 1995).  In each injection, the plasmid pRF4 [rol-6 (su1006dm)] was 
used (at approximately 150 ng µl
-1
) as a marker due to the stereotypic phenotype of a 
rolling locomotion seen in expressing animals.  F1 worms displaying the Rol phenotype 
were cloned, allowed to self-cross, and the F2 were examined for rolling progeny.  All 
injected lines were considered stable when the balancer phenotype was lost and the roller 
phenotype was observed in the 2nd generation progeny of injected worms. 
Lines expressing transcriptional fusion constructs were generated by injecting 
plasmids that contained genomic sequence upstream from the start site of each isoform 
(amplified from the cosmid F42G9 [provided by Dr. Alan Coulson, Wellcome Trust 
Sanger Centre]) fused to the coding region of the gfp gene (amplified from the cosmid 
pPD118.20 [provided by Dr. Andrew Fire, Carnegie Institute]).  Each was injected into a 
wild-type N2 background at concentrations of 5 – 10 ng µl
-1
.  The extrachromosomal 
arrays zpEx312 in the strain WB298 was generated by the injection of pJMR260.  This 
array contains the 2.389 kb genomic region upstream from the start of the K isoform of 
T17H7.4 fused to gfp.  Similarly, the extrachromosomal array zpEx313 in the strain 
WB299 was generated by the injection of pJMR255.  This array contains the 2.575 kb 
genomic region upstream from the start of the A and C isoforms of T17H7.4 fused to gfp.  
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The extrachromosomal array zpEx314 in the strain WB300 was generated by the 
injection of pJMR252.  This array contains the 2.463 kb genomic region upstream from 
the start of the J isoform of T17H7.4 fused to gfp.  
Lines expressing translational fusion constructs were generated by injecting plasmids 
that contained genomic sequence upstream from the start site (amplified from the cosmid 
F42G9 [provided by Dr. Alan Coulson, Wellcome Trust Sanger Centre]) and the coding 
region of each isoform (amplified from the cDNAs yk1043e9 (Isoform K) and yk287e3 
(Isoform C) [provided by Dr. Yuji Kohara, National Institute of Genetics, Japan] fused to 
the coding region of the gfp gene (amplified from the cosmid pPD118.20 [provided by 
Dr. Andrew Fire, Carnegie Institute]).  Each was injected into pat-12(st430) 
heterozygotes.  The extrachromosomal arrays zpEx326 [Isoform K::GFP] in the strain 
WB326 was generated by the injection of two overlapping PCR products generated using 
the template pJMR266 with the primers WB-615 and WB-616 and the template 
pJMR300 with the primers BW-617 and BW-618.  These PCR products were injected at 
10 ng µl
-1
.  Similarly, the extrachromosomal array zpEx327 [Isoform C::GFP] in the 
strain WB327 was generated by the injection of a solution containing the overlapping 
PCR products generated using the template pJMR293 with the primers BW-615 and BW-
616 and the template pJMR400 with the primers BW-617 and BW-618.  These were 
injected at 10 ng µl
-1
.   
 
Antibody Staining 
All embryos were fixed stained as described by Barstead and Waterston (Barstead 
and Waterston, 1991).  Embryos were released from gravid adults by treatment with basic 
34 
hypochlorite solution (0.5 N KOH, 1.2% NaOCl) for 7 minutes and washed four times in 
M9 buffer solution (22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl, 1mM MgSO4) 
(Sulston and Hodgkins, 1988). Embryos were fixed in a formaldehyde fixative (3% 
formaldehyde from paraformaldehyde, 0.1 M sodium phosphate, pH, 7.0, 0.1 mM 
EDTA) for 10 minutes at room temperature and washed two times with PBS, pH 7.0.  
They were then incubated -20°C methanol for 10 minutes at –4°C.  They were then 
washed two times in PBS pH 7.0.  Embryos were then incubated two times in PBS, pH 
7.0, containing 0.5% Tween-20.  Embryos were then incubated for 45 minutes in the 
primary antibody diluted in 70% PBST (PBS, pH 7.0, 0.5% Tween-20) and 30% normal 
goat serum and washed four times in PBST for 5 minutes.  Embryos were then incubated 
in secondary antibody diluted in 70% PBST (PBS, pH 7.0, 0.5% Tween-20) and 30% 
normal goat serum and washed four times in PBST for 5 minutes.  Embryos were stored 
in 50% PBS, pH 7.0 with 50% glycerol.  Embryos were then mounted and viewed. 
Primary antibodies were diluted as follows in 250 ml of 70% PBST (PBS, pH 7.0, 
0.5% Tween-20) and 30% normal goat serum:  MH4 [anti-ifa-1, 2, and 3] – 1:100, MH46 
[anti-myotactin] – 1:100 [provided by the Developmental Studies Hybridoma Bank], and 
anti-PAT-12 – 1:2000.  In each experiment, a goat anti-rat fluorescence conjugated 
secondary antibody was used, diluted 1:100 in 70% PBST (PBS, pH 7.0, 0.5% Tween-
20) and 30% normal goat serum. 
 
Antibody Generation 
PAT-12 antisera was obtained by injecting mice with a synthetic peptide [N-
CRRNLAGDFPSEHSKSKIKLDPLEQR] fused to KLH [Immunological Resource 
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Center, University of Illinois].  This sequence is shared by the A, B, C, and K isoforms of 
T17H7.4.  Polyclonal sera from injected mice were used to stain N2 (wild type) worms as 
described above.   
 
Determination of Developmental Stages 
The developmental stages of embryos and larva was determined by allowing 10 adult 
worms to lay eggs on a new plate for 1 hour, removing the adults, and allowing the 
progeny to develop for the time specified for each stage as stated by Wood (Wood, 
1988).  Specifically, the embryonic stages were defined as from 0-12 hours post laying, 
the L1 larval stage from 12-23 hours post laying, the L2 larval stage from 23-30 hour 
post laying, the L3 larval stage from 30-38 hours post laying, the L4 larval stage from 38-
47 hours post laying, and the adult stage after 47 hours post laying. 
 
DiI Staining of Amphid and Phasmid 
WB326 hermaphrodites were incubated in DiI (2 mg / ml in dimethyl formaldehyde) 
diluted 1:1500 in M9 for either 30 minutes (for amphid visualization) or 2 hours (for 
phasmid visualization).  Worms were plated to NGM plates seeded with OP50 E. coli for 
1 hour to destain and then visualized (Uchida et al, 2003). 
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Results 
 
Isoforms A, C, and K are Expressed in the Hypodermis 
To further investigate the cause of the pat-12(st430) muscle detachment and 
developmental arrest phenotype, we sought to determine the expression pattern of the 
protein products of the A, C, J and K isoforms, the protein products of the isoforms 
affected by the mutation in pat-12(st430) mutant worms.  As shown in Figure 1C, 
isoforms J and K have distinct transcriptional start sites, while isoforms A and C share a 
common start site.  We, therefore, generated three GFP transcriptional reporter constructs 
each of which included 2.3-2.5 kb of DNA upstream from the predicted start of 
translation.  In other fibrous organelle protein studies, similar length promoter sequences 
have been sufficient to drive expression (Ding et al, 2003, Karabinos et al, 2001).  The 
constructs were introduced into wild-type worms though standard transformation 
techniques. 
The reporter for isoforms A and C showed GFP expression in the hypodermis [Figs. 
2C, D] as well as in epithelial cells of the rectum, vulva, amphids and phasmids [data not 
shown].  The isoform K reporter showed an identical pattern of expression [Figs. 2E, F].  
Interestingly, the isoform J reporter showed GFP expression in the pharynx and the rectal 
epithelium [data not shown], but not in the hypodermis [Figs. 2A, B].  Given these 
expression patterns, we hypothesize that the muscle detachment phenotype in st430 
mutants is likely due to the lack of one or more of the isoforms A, C, and K in the 
hypodermis.  We, therefore, focused our investigation on the localization of isoforms A, 
C, and K within the hypodermis. 
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Anti-PAT-12 Antibody Staining 
To confirm translational fusion construct data and to determine the localization of the 
protein products of isoforms A, C and K in vivo, we generated polyclonal antibodies 
against a synthetic peptide corresponding to a region of the 5
th
 – 8
th
 exons [Star in Fig. 
1C], which is shared by the A, C, J, and K as well as the B isoforms.  Staining of wild-
type N2 worms and embryos revealed a circumferential hypodermal banding pattern that 
sub-tends the sites of body-wall muscle attachments [Fig. 3A, B] and appears identical to 
the patterns reported previously for other fibrous organelle proteins (Hresko et al, 1999).  
In addition, we observed pharyngeal staining.    
To determine localization of PAT-12 isoforms in pat-12(st430) arrested embryos, we 
stained arrested embryos with the polyclonal antiserum.  The hypodermal cells fail to 
stain in the arrested mutant animals [Fig. 3F], while the pharyngeal staining remains [Fig. 
3E].  In comparable staged wild-type control embryos, both the hypodermal [Fig. 3D] 
and pharyngeal staining patterns are visible [Fig. 3C].  These results, in combination with 
the transcriptional reporter results above, suggest that the st430 mutation blocks the 
expression of isoforms A, C, and K from the hypodermis, but does not effect the 
expression of additional pharyngeal isoform(s).  The pharyngeal signal is likely to come 
from isoform B, which should also be detected by the polyclonal antiserum and would 
not be affected by mutations to exon 12.  Taking all the results together, it is likely that 
the loss of one or more of the three isoforms A, C, and K from the hypodermis results in 
the muscle detachment and developmental arrest in the pat-12(st430) mutants.  
 
. 
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Rescue By and Location of Isoforms C and K in vivo 
To test this idea more directly, we examined whether any one of these isoforms 
individually is sufficient to rescue the pat-12(st430) homozygotes from developmental 
arrest.  We, therefore, sought to generate plasmids containing mini-genes, each of which 
would include a single isoform fused in frame to gfp.  This was attempted multiple times 
with similar results on every occasion, the resulting plasmid showed poor transformation 
rates into the E. coli and contained new mutations not present it the original cosmid.  
This, along with the previously reported large deletion in the cosmid T17H7, led us to 
speculate that the pat-12 gene is lethal to E. coli and thus acts by natural selection to 
promote those colonies that receive constructs whose inserts are mutated during the 
process of PCR.  Knowing this, we had to resort to injecting two overlapping PCR 
fragments for each isoform, one containing the promoter, one containing the coding 
region and one containing gfp.  While this was successful only on rare occasions, we 
were able to generate transgenic animals. 
We tested these transgenic mini-genes encoding either isoform C or K tagged with 
GFP and found that both on their own were sufficient to rescue the st430 embryonic 
arrest phenotype.  In contrast, repeated attempts to rescue pat-12(st430) mutants with an 
isoform A minigene failed to rescue the developmental arrest.  Our results suggest that it 
is the loss of both C and K together that leads to pat-12 developmental arrest, and that 
these two isoforms have at least partially overlapping functions.     
The C isoform mini-gene was expressed in the hypodermis [Fig. 4F], in an extension 
from the sieve to the grinder in the pharynx [Fig. 4H], and in the rectal epithelia [Fig. 
4G].  The expression of the C isoform mini-gene was highest at the early L1 larval stage 
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[Figs. 5A, B].  This expression level stayed high through the L3 larval stage [Figs. 5I, J], 
decreased through the L4 larval stage [Figs. 5M, N], and was greatly diminished by 
adulthood. 
The K isoform mini-gene was expressed in the hypodermis [Fig. 4A], vulva [Fig. 
4D], rectal epithelia [Fig. 4E], amphids [Fig. 4B], and phasmids [Fig. 4C].  To confirm 
the amphid and phasmid localization of isoform K, we incubated transgenic worms in 
DiI, which is taken up into both amphids and phasmids.  In both locations, the GFP signal 
localized to structure stained with the DiI [Data not shown].  The expression of the K 
isoform mini-gene was not visible until the late L1 larval stage [Figs. 5A, B].  Expression 
levels then started to increase throughout larval development [Figs. 5C’, D’, E’, F’, G’, 
and H’] and were highest in the adult worms. 
 
Comparison of PAT-12 and FO Protein Localization 
We have hypothesized that PAT-12 localizes to the C. elegans fibrous organelle due 
to its characteristic hypodermal banding pattern [Figs. 3A, B].  To show this directly, we 
stained worms expressing the GFP-tagged isoform K with antibodies against the known 
fibrous organelle components myotactin and the intermediate filament protein MH4.  As 
we expected, the GFP-tagged PAT-12 isoform K co-localized to circumferential bands in 
the hypodermis with both MH4 and myotactin [Fig. 6] signifying that PAT-12 most 
likely is an FO component. 
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Discussion 
Our expression data and mini-gene rescue experiments show that three of the PAT-12 
isoforms are located in the FOs of hypodermal cells, which are organized specifically at 
locations overlying muscle cell attachments.  Our mini-gene rescue experiments suggest 
that the simultaneous loss of both isoforms C and K causes developmental arrest.  
Isoform C is expressed at early stages of larval development with expression decreasing 
in late larval stages and adulthood.  Isoform K begins to be expressed at the L2 stage and 
persists through adulthood.  This suggests that while these isoforms likely overlap in 
function, they are not identical.  Also, since transgenic lines expressing only one isoform 
were not healthy, both isoforms likely perform individual functions at specific times 
during development. 
 
PAT-12 is a Component of the Fibrous Organelle 
 
We have shown both by antibody staining and with GFP-tagged PAT-12 fusion 
proteins expressed in vivo that PAT-12 isoforms C and K are components of the FO due 
to their circumferential banding pattern, which is similar to that seen in other FO proteins.  
Co-localization studies with the anti-IF antibody MH4 showed that in isoform K these 
circumferential bands were coincident with the FO intermediate filaments.  Recent high 
through-put binding studies have shown that PAT-12 binds to the intermediate filament 
IFA-2 in both yeast-2-hybrid and immunoprecipitation studies (Li et al, 2004).  These 
data, taken together, suggest highly that PAT-12 is a component of the fibrous organelle. 
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PAT-12 Expression Changes Throughout Development 
 
The translational fusion products of isoforms C and K both showed significant 
changes in expression throughout larval development.  While C was expressed highly at 
the L1 larval stage and decreased by the L4 larval stage, the K isoform showed low 
expression until the L4 larval stage and then continued to be highly expressed in the adult 
worms.  Other FO proteins showed similar changes in expression throughout 
development, suggesting that some remodeling of the fibrous organelle may occur over 
the time course of development (Hapiak et al, 2003).  Interestingly, since no GFP signal 
could be visualized at that stage in our transgenic lines, it appeared that neither the C nor 
the K isoform was highly expressed at the two-fold stage of development when the pat-
12(st430) mutant embryos arrested.  However, both were sufficient to fully rescue the Pat 
phenotype of these arrested embryos.  This would suggest that such low levels of PAT-12 
are required to rescue the mutant worms and allow for embryonic development to 
proceed that we were unable to visualize the GFP attached to them. 
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Figures 
 
Figure 3.1:  Expression Patterns of the Transcriptional Fusion Products of the Predicted J, 
A/C, and K Isoforms of pat-12 in Adult Worms. - The 5’ promoter region of each 
predicted isoform was fused to the coding region of the gfp gene to make isoform-
specific transcriptional fusion products.  These were then injected into wild-type N2 
hermaphrodites.  Isoforms A and C share a common start site and therefore only one 
transcriptional fusion product was made corresponding to both of these isoforms.  The 
transcriptional fusion products of both isoforms K (C and D) and A/C (E and F) were 
expressed in hypodermal cells in adults.  (E and F) The transcriptional fusion product 
corresponding to predicted isoform J (A and B) was not expressed in the hypodermal 
cells in adults.  The scale bars represent 15 µm. 
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Figure 3.2:  Staining of Wild Type Adult Worms, Wild Type Embryos, and pat-12 
(st430) Mutant Embryos with Anti-PAT-12 Antibody. - This antibody was generated to a 
region of pat-12 common to all predicted isoforms that are affected by the st430 mutation 
(J, A, C, and K) as well as the B isoform.  In wild-type adults, the circumferential 
banding pattern in four quadrants was seen, which is similar to that described for other 
fibrous organelle proteins (A and B).  This banding pattern was also seen in wild-type 
embryos (D) along with a pharyngeal pattern (C).  In the st430 mutant embryos, the 
hypodermal circumferential banding pattern was lost (F), but the pharyngeal pattern 
remained (E).  The scale bars represent 15 µm 
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Figure 3.3:  Co-localization of the pat-12 Isoform K Translational Fusion Product and 
Antibodies Against the Fibrous Organelle Proteins myotactin and MH4. - Adults 
expressing the gfp -tagged translational fusion product corresponding to isoform K were 
stained with antibodies against myotactin [MH46] and the intermediate filament protein 
MH4.  Isoform K (A and D) co-localized with both MH46 [MH46 alone (B), composite 
(C)] and MH4 [MH4 alone (E), composite (F)] in a hypodermal circumferential banding.  
The scale bars represent 15 µm. 
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Figure 3.4:  Expression of pat-12 Isoform Specific Translational Fusion Products in 
Rescued st430 Homozygous Mutant Adults. - The entire coding region of isoforms C and 
K were fused in frame to the gfp reporter gene and injected into st430 heterozygotes.  
Rescued progeny were cloned and examined as adults for GFP localization.  Isoform K 
was expressed in a circumferential banding pattern in four quadrants (A) that is similar to 
that described for fibrous organelle proteins.  Isoform K was also expressed in the 
amphid (B), phasmid (C), vulva (D), and rectal epithelium (E).  Likewise, isoform C 
showed a similar hypodermal banding pattern (F).  Additionally, isoform C was 
expressed in rectal epithelium (G) and the pharynx (H).  The scale bars represent 15 µm. 
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Figure 3.5:  Expression of pat-12 Isoform Specific Translational Fusion Products at 
Different Stages of Larval and Adult Development. - Rescued worms expressing the gfp 
tagged translational fusion product corresponding to isoform K were examined for 
hypodermal expression through the four larval stages.  Isoform C was expressed during 
the L1 (A and B), L2 (E and F), and L3 stage (I and J) and decreased in the L4 stage (M 
and N).    Expression of isoform K was minimal during the L1 stage (C and D).  
Expression was maintained at high levels throughout the rest of larval development [L2 
(G and H), L3 (K and L), L4 (O and P)].  The scale bars represent 15 µm. 
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CHAPTER 4: DISCUSSION 
 
Summary 
In order to enable us to use a nematode model of hemidesmosome formation, we 
sought to identify another member of the C. elegans hemidesmosome-like fibrous 
organelle complex.  We focused on a mutant strain of C. elegans that was isolated due to 
a developmental arrest phenotype, the Pat phenotype.  The mutation in this line had 
previously been mapped to an area of linkage group III between unc-45 and daf-7.  After 
finding a predicted gene in this area that displayed a Pat phenotype when exposed to the 
corresponding ssRNA, we located a mutation in this gene, T17H7.4, which would lead to 
a G to A mutation in a splice acceptor site likely resulting in the loss of the encoded 
protein.  Injection of DNA corresponding to this predicted gene rescued the pat-12(st430) 
mutants, thereby indicating that T17H7.4 is pat-12. 
Once we had identified the genetic identity of pat-12, we injected transcriptional 
fusion constructs corresponding to the isoforms affected by the st430 mutation into wild 
type worms to determine which cells expressed pat-12 and which isoforms were 
expressed in the hypodermis.  After finding that isoforms A, C, and K were expressed in 
the hypodermis, our tissue of interest, we desired to know if any of these localized to a 
pattern similar to fibrous organelle proteins.   
Using an antibody to all of these isoforms as well as isoforms J and B, we determined 
that at least one isoform did localize to the stereotypical circumferential bands.  By 
injecting translational fusion constructs corresponding to isoforms C and K, we found 
that both of these isoforms displayed the desired l
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generate a translational fusion isoform corresponding to isoform A.  Additionally, we 
noted that these isoforms co-localized with known fibrous organelle proteins.  By 
examining animals expressing these constructs over time, we saw that both isoforms 
showed changing expression levels over the course of development, specifically that the 
K isoform was expressed later in development than the C isoform. 
 
Summary of PAT-12 Paper by Hetherington et al 
As we were compiling the results described above, Hetherington et al. reported the 
results of their examination of PAT-12.  They focused on PAT-12 as a potential target for 
drugs or vaccines to limit nematode infection as PAT-12 showed homology to another 
vaccine target, B20 in Onchocerca volvulus, as described above (Taylor et al, 1995).  
They chose to focus on the mutant pat-12(tm2298), which contains a large deletion and 
which they claim has a more severe phenotype than the st430 mutant.  By both RNAi 
against T17H7.4 and by sequencing the tm2298 mutant, they determined, as we did, that 
T17H7.4 corresponds to pat-12.   
Similarly to what we had done, Hetherington et al. generated and injected 
translational fusion constructs into mutant pat-12 worms corresponding to isoforms J, A, 
K, and E.  They stated that both isoforms A and K were expressed in the hypodermis and 
localized to fibrous organelle component-like circumferential bands, but only isoform A 
was able to rescue the tm2298 mutant.  When they went on to examine the mutant worms 
by electron microscope, they found that at the two-fold stage, myotactin remained at the 
basal membrane and MUP-4 remained associated with the apical membrane in the 
progeny of wild-type worms fed ssRNA corresponding to pat-12.  They did, however, see 
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a widening of the apical-basal hypodermal distance compared to wild type.  Interestingly, 
along with this widening, they saw detachment of body wall muscle from the hypodermis 
in the head and tail region of pat-12 mutant worms (Hetherington et al, 2011). 
Through a yeast-2-hybrid screen, they confirmed previous reports that an N-terminal 
region of PAT-12 bound VAB-10.  When they examined the apical-basal hypodermal 
distance in VAB-10 depleted worms, they reported the same hypodermal widening.  In 
light of this, Hetherington et al. suggest that PAT-12 acts as an adapter interacting with 
VAB-10 both at the apical and basal membranes of the hypodermal cell to stabilize the 
fibrous organelle and state that the apical and basal functions of PAT-12 might differ 
(Hetherington et al, 2011). 
While many of our results were similar, there were key differences.  First, we were 
able to rescue the pat-12(st430) mutation using isoform K, which they were unable to do.  
Given our previously described problems generating constructs due to pat-12 seemingly 
being incompatible with bacterial growth, there may have simply been some problem 
with their construct which, though it allowed for proper localization, made rescue 
impossible.  Second, while they stated that isoform A localized to the hypodermis and not 
isoform C, we found that isoform C not only localized here, but also could rescue the 
mutants.  Since isoforms A and C differ only in one exon in the middle of the gene 
(Isoform C has the exon, isoform A lacks it), it is possible that both our constructs 
targeted the same protein.  Potentially, this exon could cause very little difference in the 
final protein (Hetherington et al, 2011). 
In these ways, the data that we generated and the data generated by Hetherington et 
al. complement each other, suggesting that PAT-12 plays a complex and possibly 
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multiple roles in FOs at the apical and basal membrane.  The differences in our results 
suggest that predicted isoform data may not be entirely correct.  Additionally, as they did 
not mention having difficulty amplifying DNA corresponding to pat-12 in bacteria, it 
could be that the differences in the ability to rescue of different isoforms may be due to 
mutations introduced into their constructs at this point in the experiment.  Sequencing of 
their constructs was not available for verification, but would be helpful before taking 
either groups results to be fully accurate.  
 
Predicted Interactions and Model of PAT-12 Function 
Additional information regarding the role of PAT-12 within the fibrous organelle 
could be gained by examining its proposed or described in vitro interactions.  Yeast-2-
hybrid results suggest that PAT-12 might function in a link between fibrous organelles 
and actin based circumferential microfilament bundles (CFBs).  PAT-12 has been 
reported to interact with IFA-1, MUA-6 / IFA-2, and IFB-2, which are intermediate 
filament proteins (Li et al., 2004, Zhang and Sternberg, 2006).  Furthermore, PAT-12 was 
reported to interact with the protein product of the predicted gene ZK849.2, which, in 
turn, was found to interact with VAB-19, a proposed actin interactor, which displays a 
Pat phenotype and is both dependent on myotactin for proper localization and necessary 
for proper myotactin localization (Li et al., 2004; Ding et al., 2003, Zhang and Sternberg, 
2006). 
Actin-based CFBs form rings within the hypodermal cells and function during 
embryonic elongation to transform the bean shaped embryo into a worm shaped larva 
without cell divisions by contraction of the hypodermal cells (Costa et al., 1997).  As 
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these bundles contract, the short axis of the hypodermal cells is squeezed forcing 
expansion of the long axis.  Studies have shown that these circumferential bundles attach 
to an exoskeletal element called the embryonic sheath, which forms the outer layer of the 
cuticle in the adult (Costa et al., 1997) and localize to areas that will be the furrows 
between annuli in the adult.  When embryonic elongation is complete, these fibers 
destabilize, but reform during larval molting events (Costa et al., 1997). 
Given the proposed interactions with both intermediate filaments and the possible 
actin-associated protein VAB-19, through ZK849.2, we propose that PAT-12 forms part 
of a critical link between FOs and CFBs [Figure 4.1].  During times during development 
when the cuticle is not present, muscles generate forces generated that cannot be 
transduced to the cuticle by the FOs.  At the two-fold stage of development, for example, 
the cuticle has not formed and therefore, it is unlikely that MUA-3 and MUP-4 can link 
the IFs to any exoskeletal structure.  pat-12 mutants, therefore, would arrest at this two-
fold stage because the loss of the PAT-12 protein leads to the uncoupling of these two 
structures and allows the muscle cells to disassociate from the hypodermal cells when the 
muscles begin to contract.   
This explains a finding that Hetherington et al. described in which muscle detachment 
at the two-fold stage in pat-12 mutants was largely confined to areas at the head and tail 
of the worm and at the bend in the embryo (Hetherington et al, 2011).  In an average 
hypodermal cell along the length of the embryo, forces generated by body wall muscles 
on one side of the cell offset forces generated by cells on the other side, resulting in a 
cumulative force vector equal to zero [Figure 4.2B].  At the head and tail, there are no 
muscle cells on the other side and thus there is a resultant force vector towards the middle 
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of the animal [Figure 4.2C].  Likewise, at the bend in the embryo, the forces are not 180 
degrees offset from each other and thus there is a resultant force vector away from the 
hypodermal cell [Figure 4.2D].  In each of these cases, we propose that without the 
cuticle to transmit forces to, the attachment between muscles and the hypodermis relies 
on a linkage to the CFBs to maintain integrity in areas where forces are not offset.  As 
this link is absent in pat-12 mutants, the muscle cells dissociate. 
During later developmental stages, this IF-actin linkage complex could serve to link 
the IFs to other actin based structures.  This could serve to stabilize and transduce muscle 
forces across the entire hypodermal cell via stress fibers.  Additionally, at times of 
molting, the FO-CFB link would be necessary as the cuticle is not present.  This is 
supported by the fact that the CFB reforms during these times (Costa et al., 1997).   
Differential binding could be achieved through the expression of different isoforms of 
PAT-12 at different developmental stages as shown with the two isoforms described 
above. 
 
Comparisons with Vertebrate Hemidesmosomes 
If one is to use the C. elegans fibrous organelle as a model to study hemidesmosomal 
organization, one needs first see if they are indeed comparable.  That is, can information 
from studying how the fibrous organelle forms be used to understand vertebrate 
hemidesmosomes.  First, though they do not contain homologous proteins, the two 
structures do share a function, that is to transmit forces, generated either internally or 
externally, to a cytoskeletal component.  Next, when each structure forms, the basally 
situated transmembrane protein, myotactin or integrin, acts to organize and localize the 
53 
structure.  From this one could suggest that other steps within the organization of these 
structures are also very similar. 
Also, in both structures, as PAT-12 is a testament to, the expression of component 
proteins changes over time.  This is also evident in the switch in expression of keratins 
during the maturation and migration of epidermal cells to the skin surface.  In both cases, 
this shows that these two are dynamic structures, able to adapt to changing intracellular 
environments.  Finally, if our model for the role of PAT-12 is correct, both have a critical 
link to the actin cytoskeleton.  As was the case with mutations in the vertebrate kindlin-1 
gene, significant phenotypes occur when this linkage is lost or weak.  Taken together, 
there is enough evidence that further study of the C. elegans fibrous organelle will yield 
information that will be applicable to the vertebrate hemidesmosome. 
 
Questions for Future Study 
The differences between our data and that reported by Hetherington et al. regarding 
the capacity of the different isoforms of PAT-12 to rescue the mutant phenotype suggests 
that the sequences of the predicted isoforms may not be absolutely correct.  To fully 
determine which isoform(s) are able to rescue, future study should focus on which 
isoforms are actually transcribed by the organism.  To this end, we propose to undergo 
RT-PCR analysis of the transcripts of pat-12.  This could also potentially identify new 
transcripts that have not been proposed prior to this.  Another benefit of this line of study 
would be that, when worms at different stages are used as the source of the mRNA, one 
could examine if there is indeed a difference in the isoforms expressed over the course of 
development.  While our data suggests that this is the case, it does have the limitation of 
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being based on a transgenic rescued animal whose gene number and expression, though 
proposed to be very similar to wild type, may not be so (that is, these animals may have 
an increased pat-12 gene copy number, for example).  Only by examining real expression 
at a known point in development can we truly state that expression changes over time in 
wild type animals. 
The work described above allows for only a small of understanding both how the 
fibrous organelle and the hemidesmosome form and change over time.  To begin to tease 
apart this we will first need to establish that PAT-12 is part of a link between fibrous 
organelles and the CFBs.  Additionally, we will need to identify conclusively the other 
members of this link beginning with characterizing the ZK849.2 protein.  From here, we 
would like to identify other members of the FO, both Pats and non-Pats.  Furthermore, 
given the changed in FO protein expression over development seen between the different 
PAT-12 isoforms, we would like to know if the FO present at larval molting stages is 
composed of the same proteins as that present during embryogenesis.  Finally, when we 
have put this altogether, we will focus on elucidating the complex series of events that 
allow for FO formation and correct spatial localization.  Once we know this, we can use it 
as a template for understanding the process by which a hemidesmosome forms.  
Once the identities and sequences of expressed isoforms have been identified and 
other members of the FO complex have been identified, two distinct lines of study could 
take place.  The first of these would be examination of the isoforms structure and 
sequence for similarities with vertebrate proteins as well as differences between isoforms.  
As described above, previous sequence analysis has failed to produce any vertebrate 
homologs or identified domains.  Any differential splicing could alter these results, 
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however.  Additionally, while the sequences may not be identical, protein structure could 
be similar enough to suggest overlapping function between PAT-12 and a vertebrate 
hemidesmosome protein.  Protein folding analysis and 3D structure modeling could 
suggest this as well as giving information about differences in conformation of different 
isoforms, which could explain their differential expression during development.   Finally, 
by knowing the sequences of expressed transcripts and by seeing what sequences likely 
form acting sites in the 3D modeled protein, one could hypothesize which protein 
domains form the key parts of the molecule.  This data could guide mutant generation to 
elucidate which domains are necessary for PAT-12 function. 
The other line of experimentation that would now be possible would be those that 
would identify the temporal organization of the FO, both during initial formation and 
with changes over the course of development.  Specifically, we would determine 
mutations in which genes lead to mislocalization of PAT-12.  Conversely, we could find 
what proteins are mislocalized in pat-12 mutants, as Hetherington et al. began to do.  
Once these interactions are known, it would theoretically be possible to determine the 
structure of the FO in space, especially through the use of electron microscopy as 
Hetherington et al demonstrated.  By using our own binding data as well as the data from 
large scale Yeast-2-Hybrid screens, it would be possible to identify all FO members and 
might lead to the discovery of vertebrate homologs.  All these lines of experimentation 
would be possible and would result in a greater understanding of the FO and possibly the 
vertebrate hemidesmosome thanks to what we now know about PAT-12. 
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Figures 
 
Figure 4.1: Predicted Model of PAT-12 Function. - PAT-12 is predicted to link the 
fibrous organelle to the circumferentially oriented actin fibers through ZK849.2 and 
VAB-19.  Linking these two structures provides additional support especially at time 
when the cuticle is not present. 
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Figure 4.2:  Schematic Representation of Force Vectors Resulting From Muscle 
Contractions in Different Areas of Two-fold Embryo. (A) An embryo arrested at the two-
fold stage.  (B) Contraction of muscles (gray box) in areas of the embryo that remain 
straight have offsetting forces (black arrows) as seen by the hypodermal cell (red box).  
(C) At the head and tail, a force vector (blue arrow) is present in the direction of the 
worm body when the muscle cells contract.  This likely causes the muscle cells to detach 
when PAT-12 is absent.  (D) Likewise, at bends in the embryo, the muscle cells are no 
longer 180 degrees apart from one another and thus a force vector is present, causing 
muscle detachment described in Hetherington et al. 
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